Schizophrenia is a form of mental disorder that exerts a substantial impact on social
functioning. One of the predominant issues is the difficulty in recognising facial emotions …

Deficits in social cognition, including emotional processing, are hallmarks of schizophrenia
and antipsychotic agents seem to be ineffectual to improve these symptoms. However …

Impaired facial emotion recognition is a core deficit in schizophrenia. Oxytocin has been
shown to improve social perception in patients with schizophrenia; however, the effect of …

Objective Difficulties in social cognition are common in individuals with schizophrenia (SZ)
and are not ameliorated by antipsychotic treatment. Intranasal oxytocin (OT) administration …

Background Individuals with schizophrenia have functionally significant deficits in automatic
and controlled social cognition, but no currently available pharmacologic treatments reduce …

Schizophrenia is often a severe and debilitating mental illness, frequently associated with
impairments in social cognition that hinder individuals' abilities to relate to others and …

Schizophrenia is characterized by persistent cognitive deficits that significantly impact
functional outcomes. Despite the current available treatments, these deficits remain …

Oxytocin has numerous prosocial and antipsychotic-like effects in animals. Prosocial effects
of acute intranasal oxytocin administration have also been reported in human subjects. We …

The effects of intranasal oxytocin, a neuropeptide involved in prosocial behavior and
modulation of neural networks underlying social cognition and emotion regulation, have …

BackgroundStudies have suggested that patients with schizophrenia are impaired at
recognizing emotions. Recently, it has been shown that the neuropeptide oxytocin can have …